Clinical Trial Update: Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage [Phase 4]

View source ↗

Summary

This Phase 4 trial compares stepped dosing of efavirenz with the usual dose and reports on the incidence and severity of neuropsychiatric adverse events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• efavirenz (Sustiva) (efavirenz)

Snippet

Sponsor: Sociedad Andaluza de Enfermedades Infecciosas | Conditions: HIV-1 Infection, HIV Infection | Phase 4 | Status: COMPLETED